Design Validation of Senofilcon A With New UV-blocking Additive

NACompletedINTERVENTIONAL

Enrollment

253

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

November 1, 2018

Study Completion Date

November 1, 2018

Conditions

Visual Acuity

Interventions

DEVICE

senofilcon A TEST Lens

JJVC Investigational Contact Lens

DEVICE

senofilcon A CONTROL Lens

Acuvue Oasys

Trial Locations (10)

Tallahassee Eye Center, Tallahassee

Maitland Vision Center, Maitland

Bradley Hines, OD, Memphis

ProCare Vision Centers, Granville

Professional Vision Care, Inc, Westerville

Ziegler Leffingwell Eyecare, New Berlin

Eyecare Associates LLP, Bloomington

Kannarr Eye Care, Pittsburg

Frazier Vision, Inc, Tyler

James T. Fujimoto, OD, Cupertino

All Listed Sponsors

lead

Johnson & Johnson Vision Care, Inc.

INDUSTRY

NCT03707821 - Design Validation of Senofilcon A With New UV-blocking Additive | Biotech Hunter | Biotech Hunter